Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about NASDAQ:CADL Recent news which mentions NASDAQ:CADL Candel Therapeutics' (NASDAQ: CADL) enLIGHTEN Discovery Platform Aims To Tackle Complexities Of Tumor Microenvironments June 14, 2024 Tickers CADL Tags NASDAQ:CADL From News Direct Candel Therapeutics’ (NASDAQ: CADL) Lead Candidate CAN-2409 Combats Lung, Pancreatic And Prostate Cancers With Fast Track Designation For Three Cancers June 07, 2024 Tickers CADL Tags NASDAQ:CADL From News Direct Candel Therapeutics (NASDAQ: CADL) Reports Positive Data From Phase 2 Trial Of CAN-2409 In Borderline Resectable Pancreatic Cancer June 03, 2024 Tickers CADL Tags NASDAQ:CADL From News Direct CADL Stock Earnings: Candel Therapeutics Reported Results for Q1 2024 May 14, 2024 Tickers CADL Tags CADL Market News NASDAQ:CADL From InvestorPlace CADL Stock Earnings: Candel Therapeutics Misses EPS for Q4 2023 March 28, 2024 Tickers CADL Tags CADL Market News NASDAQ:CADL From InvestorPlace Candel Therapeutics (NASDAQ: CADL) Lead Product Candidate CAN-3110 Demonstrates Promise To Treat Deadly Brain Tumors March 15, 2024 Tickers CADL Tags NASDAQ:CADL From News Direct Moving Fast: Candel’s (NASDAQ: CADL) CAN-3110 Granted FDA Fast Track Designation For Recurrent High-Grade Glioma Following Fast Track Designation For CAN-2409 In Pancreatic Cancer February 28, 2024 Tickers CADL Tags NASDAQ:CADL From News Direct Candel Therapeutics Sets Stage For Success With Cancer-Fighting Immunotherapies February 15, 2024 Tickers CADL Tags NASDAQ:CADL From News Direct Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.